Sleep drug developer Apnimed rises on market debut (APMD)
· seekingalpha.com
Apnimed (APMD) stock gains in its first trading session after the sleep drug maker priced its upsized initial public offering of 12M shares at $16 each. Read more here.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...